Archive | April, 2012

A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen In myocardial infarction study (AVOID Study)

 The role of routine supplemental oxygen for patients with uncomplicated acute myocardial infarction (AMI) has recently been questioned. There is conflicting data on the possible effects of hyperoxia on ischemic myocardium. The few clinical trials examining the role of oxygen in AMI were performed prior to the modern approach of emergent reperfusion and advanced medical […]

Leave a comment Continue Reading →

New Data on Risks when Renin Inhibitor Aliskiren (Rasilez) is Used With ARBs or ACE Inhibitors

The US Food and Drug Administration (FDA) is warning of possible risks when using blood pressure medicines containing Aliskiren (Rasilez) with angiotensin converting enzyme(ACE) inhibitors and angiotensin receptor blockers (ARBs) in patients with diabetes or renal impairment. These drug combinations should not be used in patients with diabetes. In addition, a new warning is being […]

Leave a comment Continue Reading →